MarketAxess vs Oppenheimer
MKTX and OPY side by side, both in security brokers, dealers, and flotation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MKTX and OPY compare
MarketAxess is the larger company, worth 5.9 times as much as Oppenheimer ($5.8B against $980M).
On earnings, Oppenheimer is cheaper: it trades at 12.4× trailing earnings, against 20.2× for MarketAxess.
Oppenheimer grew revenue faster over the last twelve months (13.9% versus 3.9% for MarketAxess).
MarketAxess keeps more of each dollar of sales as profit, with a net margin of 33.5% compared with 4.9% at Oppenheimer.
Both pay dividends: MarketAxess yields 2.3% and Oppenheimer 0.83%.
MarketAxess scores higher on the StockData Score (14 against 13 for Oppenheimer), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MKTX | OPY |
|---|---|---|
| Size and price | ||
| Market cap | $5.8B | $980M |
| Share price | $165.31 | $91.45 |
| Change, 1 year | −2.3% | 35.1% |
| Change, 5 years | −54.1% | 75.3% |
| Beta (5Y) | 0.62 | 0.83 |
| Employees | 868 | 2,947 |
| StockData Score | ||
| Total score | 14 (better) | 13 |
| Valuation score | 3 | 3 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 (better) | 1 |
| Health score | 4 | 4 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 20.2× | 12.4× (better) |
| P/S | 6.7× | 0.6× (better) |
| P/B | 4.6× | 1.0× (better) |
| EV/EBITDA | 13.2× | 7.5× (better) |
| P/FCF | 16.5× (better) | 17.1× |
| PEG | – | 0.17 |
| FCF yield | 6.1% (better) | 5.9% |
| Fair value | $194.08 | $114.16 |
| Margin of safety | 14.8% | 19.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.9% | 13.9% (better) |
| Revenue growth, 5Y average | 4.2% | 6.4% (better) |
| Net income growth (TTM) | 33.0% (better) | 2.2% |
| EPS growth (TTM) | 38.9% (better) | −0.94% |
| EPS growth, 5Y average | −3.3% | 7.0% (better) |
| Profitability | ||
| Operating margin | 39.1% (better) | 7.2% |
| Net margin | 33.5% (better) | 4.9% |
| FCF margin | 40.4% (better) | 3.3% |
| Return on equity | 22.0% (better) | 9.1% |
| Return on invested capital | 30.3% (better) | 9.4% |
| Financial health | ||
| Debt / equity | 0.07 (better) | 0.00 |
| Net debt / EBITDA | −0.69 | – |
| Interest coverage | 47.6× | – |
| Altman Z-score | 5.44 (better) | 1.05 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% (better) | 0.83% |
| Payout ratio | – | 21.5% |
| Years of dividend growth | 12 (better) | 2 |
| Dividend growth, 5Y average | 4.8% (better) | −13.4% |
| Buyback yield | 5.2% (better) | 0.24% |
| Shareholder yield | 7.5% (better) | 1.1% |
| Ownership | ||
| Held by institutions | 111% | 41.7% |
| Held by insiders | 2.5% | 6.0% |
| Insider net buying, 12 months | −$1.2M | −$424K (better) |
| Short interest, % of float | 11.4% | 1.1% |
Go deeper
- MKTX stock overview
- MKTX income statement
- MKTX valuation and score
- OPY stock overview
- OPY income statement
- OPY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.